Recombinant rabbit monoclonal antibody of acth, preparation method and application thereof
The screening and preparation of ACTH recombinant rabbit monoclonal antibodies through phage display technology solves the problems of insufficient specificity and sensitivity of ACTH monoclonal antibodies in the existing technology and realizes efficient detection of hypertension-related diseases.
Patent Information
- Application Number
- CN202310142820.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-02-21
- Publication Date
- 2025-10-10
- Estimated Expiration
- 2043-02-21
AI Technical Summary
The existing technology lacks ACTH monoclonal antibodies with strong specificity, high sensitivity and good affinity, which makes the diagnosis of hypertension difficult, especially in adrenal insufficiency and Cushing's syndrome.
Phage display technology is used to screen and prepare ACTH recombinant rabbit monoclonal antibodies. By designing specific amino acid sequences and FR regions, the specificity and affinity of the antibody are improved. Chemical labels and biological markers are used for coupling and application in the detection of hypertension-related diseases.
It provides a recombinant rabbit monoclonal antibody against ACTH with strong specificity, high sensitivity and good affinity, which can stably and accurately detect adrenocorticotropic hormone and improve the accuracy and sensitivity of hypertension diagnosis.